About
Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, and South America. The company manufactures APIs and bulk drugs, such as antifungals, anaethetics, immuno suppressants, anginotensin receptor blocker, and intermediates for antifungals. It also manufactures lyophilized injections for antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments. In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. Further, it engages in contract and bulk drug manufacturing business. Gufic Biosciences Limited was founded in 1970 and is based in Mumbai, India.
Key Metrics
as of Sep 2026Market Cap4,452 Cr
P/E60.60
Div Yield0.02 %
Book Value₹66.30
52w High₹454.00
52w Low₹268.00
Face Value₹1.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 261.00 | 252.00 | 231.00 | 237.00 | 224.00 | 205.00 | 208.00 | 204.00 | 203.00 | 195.00 | 202.00 | 215.00 |
| Expenses | 214.00 | 205.00 | 198.00 | 199.00 | 190.00 | 179.00 | 174.00 | 166.00 | 167.00 | 161.00 | 165.00 | 176.00 |
| Operating Profit | 47.00 | 47.00 | 33.00 | 38.00 | 33.00 | 26.00 | 34.00 | 39.00 | 36.00 | 34.00 | 36.00 | 39.00 |
| OPM % | 18.00 | 19.00 | 14.00 | 16.00 | 15.00 | 13.00 | 16.00 | 19.00 | 18.00 | 18.00 | 18.00 | 18.00 |
| Other Income | 0.00 | -1.00 | 1.00 | 2.00 | 1.00 | 0.00 | 2.00 | 0.00 | 1.00 | 1.00 | 0.00 | 0.00 |
| Depreciation | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 |
| Interest | 9.00 | 9.00 | 8.00 | 10.00 | 9.00 | 8.00 | 5.00 | 5.00 | 5.00 | 4.00 | 3.00 | 4.00 |
| Profit before tax | 30.00 | 29.00 | 18.00 | 23.00 | 17.00 | 11.00 | 26.00 | 29.00 | 28.00 | 27.00 | 30.00 | 31.00 |
| Tax % | 26.00 | 24.00 | 30.00 | 26.00 | 24.00 | 27.00 | 26.00 | 26.00 | 26.00 | 26.00 | 25.00 | 25.00 |
| Net Profit | 22.00 | 22.00 | 12.00 | 17.00 | 13.00 | 8.00 | 19.00 | 22.00 | 21.00 | 20.00 | 22.00 | 23.00 |
| EPS in Rs | 2.22 | 2.18 | 1.24 | 1.68 | 1.30 | 0.77 | 1.93 | 2.17 | 2.08 | 2.00 | 2.22 | 2.39 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 |
|---|---|---|---|
| Sales | 944.00 | 820.00 | 807.00 |
| Expenses | 793.00 | 684.00 | 657.00 |
| Operating Profit | 151.00 | 136.00 | 150.00 |
| OPM % | 16.00 | 17.00 | 19.00 |
| Other Income | 3.00 | 4.00 | 0.00 |
| Interest | 37.00 | 25.00 | 17.00 |
| Depreciation | 31.00 | 21.00 | 17.00 |
| Profit before tax | 87.00 | 94.00 | 116.00 |
| Tax % | 26.00 | 26.00 | 26.00 |
| Net Profit | 64.00 | 70.00 | 86.00 |
| EPS in Rs | 6.40 | 6.95 | 8.59 |
| Dividend Payout % | 2.00 | 1.00 | 1.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 |
|---|---|---|---|
| Equity Capital | 10.00 | 10.00 | 10.00 |
| Reserves | 655.00 | 591.00 | 523.00 |
| Borrowings | 405.00 | 336.00 | 333.00 |
| Other Liabilities | 273.00 | 232.00 | 227.00 |
| Total Liabilities | 1,342.00 | 1,169.00 | 1,093.00 |
| Fixed Assets | 491.00 | 506.00 | 159.00 |
| CWIP | 22.00 | 22.00 | 307.00 |
| Investments | 2.00 | 2.00 | 2.00 |
| Other Assets | 827.00 | 640.00 | 625.00 |
| Total Assets | 1,342.00 | 1,169.00 | 1,093.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 |
|---|---|---|---|
| Cash from Operating Activity | 45.00 | 123.00 | -7.00 |
| Cash from Investing Activity | -31.00 | -71.00 | -102.00 |
| Cash from Financing Activity | 32.00 | -37.00 | 82.00 |
| Net Cash Flow | 46.00 | 15.00 | -27.00 |
| Free Cash Flow | 14.00 | 52.00 | -116.00 |
| CFO/OP % | 38.00 | 107.00 | 13.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 |
|---|---|---|---|
| Debtor Days | 115.00 | 140.00 | 149.00 |
| Inventory Days | 281.00 | 211.00 | 188.00 |
| Days Payable | 172.00 | 155.00 | 156.00 |
| Cash Conversion Cycle | 224.00 | 197.00 | 181.00 |
| Working Capital Days | 80.00 | 93.00 | 97.00 |
| ROCE % | 12.00 | 13.00 | — |
Corporate Actions
24 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Dividend | 22 Sep 2025 | 22 Sep 2025 | — | 0.10 | |
| Dividend | 17 Sep 2024 | — | — | 0.10 | |
| Dividend | 21 Sep 2023 | — | — | 0.10 | |
| Dividend | 24 Aug 2022 | — | — | 0.10 | |
| Dividend | 09 Sep 2021 | — | — | 0.10 | |
| Dividend | 03 Nov 2020 | — | — | 0.05 | |
| Dividend | 20 Sep 2019 | — | — | 0.05 | |
| Other | 20 Sep 2019 | — | — | — | Annual General Meeting/Dividend - Rs 0.05 Per Equity Share |
| Dividend | 19 Sep 2018 | — | — | 0.05 | |
| Dividend | 28 Aug 2017 | — | — | 0.05 | |
| Dividend | 19 Sep 2016 | — | — | 0.05 | |
| Dividend | 22 Sep 2015 | — | — | 0.05 | |
| Dividend | 18 Sep 2014 | — | — | 0.05 | |
| Dividend | 19 Sep 2013 | — | — | 0.05 | |
| Dividend | 02 Sep 2013 | — | — | 0.05 | |
| Dividend | 16 Aug 2012 | — | — | 0.05 | |
| Dividend | 16 Sep 2011 | — | — | 0.05 | |
| Dividend | 20 Sep 2010 | — | — | 0.05 | |
| Dividend | 17 Sep 2009 | — | — | 0.05 | |
| Dividend | 11 Dec 2008 | — | — | 0.05 | |
| Dividend | 19 Mar 2008 | — | — | 0.05 | |
| Dividend | 20 Sep 2006 | — | — | 0.16 | |
| Dividend | 22 Sep 2005 | — | — | 0.22 | |
| Dividend | 10 Sep 2001 | — | — | 0.50 |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update10 Nov 2025 from icra
-
Rating update8 Oct 2025 from crisil
-
Rating update1 Aug 2024 from icra
-
Rating update11 Jul 2024 from crisil
-
Rating update30 Aug 2023 from icra
-
Rating update5 May 2023 from crisil